返回
Repligen Corp（RGEN）價格
RGEN 股價走勢圖
RGEN 收益
Repligen Corp
$162.02
0.2%
$0.33
收盤價：Jan 16, 16:00:00 GMT-5
$162.02
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$161.69
開盤價
$162.29
當日範圍
$161.16 - $165.15
52週區間
$102.96 - $182.52
交易量
625.0K
平均成交量
840.8K
每股盈餘 (TTM)
0.03
股息收益率
--
市值
$9.1B
什麼是 RGEN？
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 1,778 full-time employees. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.